SELLAS Life Sciences Group, Inc. (SLS)
NASDAQ: SLS · Real-Time Price · USD
2.770
+0.130 (4.92%)
At close: Dec 23, 2025, 4:00 PM EST
2.780
+0.010 (0.36%)
After-hours: Dec 23, 2025, 4:13 PM EST
SLS Market Cap
SLS has a market cap or net worth of $393.14 million as of December 23, 2025. Its market cap has increased by 407.80% in one year.
Market Cap
393.14M
Enterprise Value
353.69M
1-Year Change
407.80%
Ranking
Category
Stock Price
$2.77
Market Cap Chart
Since January 2, 2018, SLS's market cap has increased from $38.66M to $393.14M, an increase of 916.82%. That is a compound annual growth rate of 33.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 22, 2025 | 376.05M | 413.75% |
| Dec 31, 2024 | 73.20M | 115.37% |
| Dec 29, 2023 | 33.99M | -30.05% |
| Dec 30, 2022 | 48.59M | -44.69% |
| Dec 31, 2021 | 87.85M | 59.80% |
| Dec 31, 2020 | 54.97M | 162.42% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jan 2, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 959.35B |
| Johnson & Johnson | 497.21B |
| AbbVie | 400.88B |
| UnitedHealth Group | 296.59B |
| AstraZeneca | 283.55B |
| Novartis AG | 261.76B |
| Merck & Co. | 250.91B |
| Abbott Laboratories | 218.14B |